Interestingly, this did not align with phosphorylation levels of effector proteins within these pathways in our panel of NSCLC cell lines as they exhibited heterogeneous phosphorylation levels that were cell line-specific, rather than KRAS mutant isoform-specific. Here, KRAS is linked to non-small cell lung carcinoma.